-
81
Progress in immunotherapy for brain metastatic melanoma
Published 2025-01-01Subjects: Get full text
Article -
82
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
83
Unusual gingival presentation following treatment with pembrolizumab
Published 2024-03-01Subjects: Get full text
Article -
84
PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer
Published 2025-01-01Subjects: Get full text
Article -
85
Machine-Learning Parsimonious Prediction Model for Diagnostic Screening of Severe Hematological Adverse Events in Cancer Patients Treated with PD-1/PD-L1 Inhibitors: Retrospective...
Published 2025-01-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
86
The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
87
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01Subjects: Get full text
Article -
88
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
89
Toxic epidermal necrolysis induced by nivolumab therapy for unresectable intraperitoneal cancer
Published 2025-01-01Subjects: “…checkpoint inhibitors…”
Get full text
Article -
90
-
91
-
92
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
Published 2025-02-01Subjects: Get full text
Article -
93
Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
Published 2022-06-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
94
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
Published 2025-12-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
95
Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
96
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trial...
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
97
Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer
Published 2025-03-01Subjects: Get full text
Article -
98
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
99
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Subjects: Get full text
Article -
100
A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma
Published 2025-03-01Subjects: “…immune-checkpoint inhibitors…”
Get full text
Article